Anaergia and Capwatt Partner to Launch Metanext Biogas Facility in Italy

Anaergia ( (TSE:ANRG) ) has shared an update.

Anaergia Inc., through its subsidiary Anaergia S.r.l., has signed a C$7.3 million contract with Capwatt Biomethane Unipessoal, Lda to design and construct the Metanext anaerobic digestion facility in Italy. This project is the first of nine planned facilities aimed at enhancing Europe’s green energy infrastructure and accelerating biomethane production, with a total expected revenue of over C$60 million. The Metanext facility will produce 7.6 million cubic meters of biomethane annually, marking a significant step in sustainable energy production and the energy transition in Europe.

The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.

Spark’s Take on TSE:ANRG Stock

According to Spark, TipRanks’ AI Analyst, TSE:ANRG is a Neutral.

Anaergia, Inc.’s overall stock score is impacted by significant financial instability, characterized by declining revenues and negative equity. While technical analysis and recent corporate events provide some potential for recovery, substantial risks remain due to the company’s financial challenges and lack of profitability.

To see Spark’s full report on TSE:ANRG stock, click here.

More about Anaergia

Anaergia is a pioneering technology company in the renewable natural gas (RNG) sector, focusing on converting organic waste into sustainable solutions like RNG, fertilizer, and water. With over 250 patents, Anaergia is a leader in the RNG industry, offering integrated solutions for waste processing, wastewater treatment, and biomethane production, significantly reducing environmental impact and costs.

Average Trading Volume: 73,665

Technical Sentiment Signal: Buy

Current Market Cap: C$202.1M

Find detailed analytics on ANRG stock on TipRanks’ Stock Analysis page.